McKesson Signs Agreement to Acquire Precision Medicine Group, LLC
McKesson Corporation signed a definitive agreement to acquire Precision Medicine Group, LLC for approximately $2.25 billion to enhance its clinical research and biopharma commercialization services. The target, a global provider of clinical research and commercialization services, will report into McKesson’s Oncology & Multispecialty segment upon the transaction's closing.
Key figures
- Deal Value Usd
- 2250000000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.